Three distinct T-cell precursors: bone marrow cells that express low levels of the Thy-1 antigen but no lineage markers (Thy-l-lo/BM); CD4-, CD8-, and CD3-thymocytes that express low levels of the Thy-1 antigen (Thy-l-lo/Thym); and CD4-, CD8-, and CD3-thymocytes that express high levels of the Thy-1 antigen and the IL-2 R cz chain (Thy-1 // IL2R /) were isolated by fluorescence-activated cell sorter (FACS). These three populations expanded with different kinetics in the thymus of irradiated recipient mice after intrathymic transfer. When a high dose of human recombinant IL-2 (r-IL-2) or human recombinant IL-6 (r-IL-6) was administered, r-IL-6 accelerated donor Thy-1 +/IL2R to differentiate, whereas r-IL-2 blocked normal differentiation and expansion of donor Thy-l-lo/Thym, but did not show any significant effect on donor Thy-1 //IL2R /. Neither r-IL-2 nor r-IL-6 worked directly on donor Thy-lalo/BM in this transfer system.
INTRODUCTION
Development of T cells in the thymus can be divided into two major processes: early T-cell development before the acquirement of T-cellreceptor (TCR) expression and TCR-mediated maturation of T cells such as "positive" and "negative" selections. Early events of TCR-independent T-cell development are further characterized by (1) commitment of stem cells to T-cell lineage, presumably in the bone, marrow, (2) migration of precursor T cells into the thymus, and (3) rearrangement of TCR genes before expressing CD4/CD8 differentiation antigens. All of these processes are essential to provide progenitor cells that are to be selected within the thymus and eventually cover all the T-cell reper-,toire required.
Recently, a number of studies have been carried out to fractionate CD4-/CD8- (double-negative) thymocytes on the basis of cell-surface phenotypes, such as Thy-1, Ly-1, Pgp-1, interleukin-2 receptor (IL-2R), J11d, and B2A2 (Ceredig et al., 1985; Fowlkes et al., 1985; Raulet, 1985; Husman et Scollay and Shortman, 1985; Rearse et al., 1989) . Previously, we identified the most immature double-negative thymocyte population that lacks IL-2R and CD3 expression, but expresses low levels of the Thy-1 antigen (Nakano et al., 1987) . These cells reconstituted T cells in irradiated host mice when they were transferred intravenously. There is also a distinct population of double-negative thymocytes that expresses high levels of Thy-1 and IL-2R, and is known to give rise to mature thymocytes efficiently when they are injected into the thymus directly (Shimonkevitz et al., 1987) . It has been demonstrated that purified stem cells from the bone marrow have a potential to give rise to T cells when they are injected intrathymically. Such cells lack differentiation markers such as T cells, B cells, macrophages, and granulocytes, but express the Sca-1 antigen and low levels of the Thy-1 antigen (Spangrude et al., 1988) . Although precursors in the thymus and in the bone marrow are apparently different, it is still obscure in what stage of differentiation they are and what kind of growth factors are required for their expansion and differentiation.
IL-2 induces proliferation of activated T cells. However, it is not clear how IL-2 is involved in T-cell ontogeny, although a certain population of thymocytes are known to express the c chain of IL-2R. Recently, one of the pleiotropic factors, interleukin-6 (IL-6) (Hirano and Kishimoto, 1990) , also 78 N. NAKANO, H. KIKUTANI AND T. KISHIMOTO has been reported to work as a T-cell growth factor (Le et al., 1988; Uttenhove et al., 1988) , and it is possible that IL-6 plays a role in thymocyte development.
In an attempt to understand the differentiation process of precursor T cells, we took advantage of intrathymic injection (Goldschneider et al., 1986) , combining with the three-color fluorescence-activated cell sorter (FACS) to isolate distinct T-cell precursors and to chase the fate of only donor-derived thymocytes in the host thymus. Effects of IL-2 and IL-6 on the development of T cells were also studied in this experimental system by administration of a relatively large amount of human recombinant IL-2 (r-IL-2) or human recombinant IL-6 (r-IL-6) to recipient mice that had been injected with sorted pre-B cursor T cells.
RESULTS

Capacity of Expansion and the Stage of Development of Precursor T Cells
On the basis of Thy-1 and IL-2-R expression, double-negative and CD3-negative C3H/HeN thymocytes were subfractionated into three populations, IL-2-R / and IL-2-R-thymocytes (Thy-l+/ IL2R / and Thy-I//IL2R -, respectively), both of which express high levels of the Thy-1 antigen, and thymocytes with low levels of the Thy-1 antigen (Thy-l-lo/Thym) (Nakano et al., 1987) . Bone marrow cells expressing low levels of the Thy-1 antigen (Thy-l-lo/BM), which have been demonstrated to give rise to T cells as well as all lineages of hematopoietic cells (Muller-Sieburg et al., 1986) Fig. 1B(a) . A delay in expansion of donorderived thymocytes was observed when I xl0 Thy-1-1o/Thym was injected. Although cells detected as Thy-l.2 / expressed mostly both CD4 and CD8 on day 12, their cell number was only tenfold higher than that of injected cells, Fig. 1A and Fig. 1B(b) . They continued to expand and reached the maximum level on day 21 with one hundredfold expansion. As shown in Fig. 1B(b In this system, the kinetics and the extent of expansion and differentiation appear to indicate the differentiation stage of precursor T cells; Thy-l// IL2R-is the most differentiated population because of its incapability of expansion, and Thy-I+/IL2R / is more differentiated than Thy-l-lo/Thym, which was indicated by its delayed kinetics of thymus reconstitution. Thy-l-lo/BM differs completely from Thy-1-lo/Thym in terms of capacity of expansion and duration of reconstitution, although its phenotype is similar to Thy-l-lo/Thym. Promotes Thy-I+/IL2R + to Differentiate into CD4+/CD8 + and CD4+/CD8
We enployed this transfer system to investigate the effects of r-IL-2 and r-IL-6 on the reconstitution of the thymus by three T-progenitor populations: Thy-I//IL2R +, Thy-l-lo/Thym, and Thy-l-lo/BM, all of which were capable to expand in the thymus, as described before. First, irradiated AKR/J recipients were intrathymically transferred with Thy-I//IL2R + C3H/HeN cells and then injected with saline, 10 g of r-IL-2, or 10 g of r-lL-6 every day. By gating on donor-derived Thy-l.2 positive cells, the expression of CD4 and CD8 on the donor-derived thymocytes was analyzed on day 11. As shown in Fig. 2A , surface phenotypes of donor-derived cells were mostly CD4+/CD8 / at this point. The relative proportion of CD4-/CD8-cells in r-IL-6-treated mice was lower than in the control, Fig. 2A(c) Thy-l-lo/Thym Thy-l-lo/Thym was similarly injected into the thymus of irradiated recipients and 10/g of either r-IL-2 or r-IL-6 were administered every day. On day 14, mice were sacrificed and CD4 and CD8 expressions of Thy-l.2 / donor-derived thymocytes were analyzed. Although phenotypes of thymocytes in r-IL-6-treated recipients were similar to those in saline-treated controls, Fig. 2B (a) and (c), more progeny derived from Thy-l-lo/Thym was detected in r-IL-6-treated mice than in controls on day 14 ( Fig. 2B(b) . Interestingly, actual cell numbers of all populations, particularly 80 N. NAKANO, H. KIKUTANI AND T. KISHIMOTO '! "l 'to "'i60 CD8 CD8 CD8
Exp. Human r-IL-2 (10 #g), r-IL-6 (10/g), or saline was administered to the recipients once a day until the day before the analysis. Numbers of donor-derived cells (Thy-l.2 /) were calculated from the number of total thymocytes in the recipient mouse and the data of the three-color FACS analysis.
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Exp. Exp. Fig. 2C(a) , the main population of transferred cells was double positive and phenotypic patterns of thymocytes were almost identical among three treatments. (Fig. 2C) . We did not find any clear effect of r-IL-6 on the expansion of progeny of Thy-l-lo/BM cells, as shown in (Nakano et al., 1987) , failed to expand in the thymus (Fig. 1A) (Nakano et al., 1987) . In the previous experiment (Nakano et Katsura et al. (1988) from their intrathymic transfer experiments using unfractionated cells from thymus, bone marrow (BM), and spleen as a source of T-cell progenitors. These findings suggest that precursors in the thymus have a poor self-renewal activity compared to those in BM. However, it is likely that Thyol-lo/BM still includes hematopoietic progenitors of different stages such as Thy-l-lo/Sca-1 / pluripotent stem cells (Spangrude et al., 1988) . Therefore, there are two possibilities: (1) pluripotent hematopoietic stem cells, which have self-renewal activity, may participate in the expansion and differentiation exclusively to T-cell lineage in the thymus, or (2) a certain progenitor population in Thy-l-lo/BM, which is already committed to T lineage, but more immature than Thy-l-lo/Thym, may be the cells responsible for the reconstitution of the thymus. In fact, it was reported that Thy-l-lo/Sca-1 + pluripotent stem cells could reconstitute the thymus when they were transferred intrathymically (Spangrude et al., 1988 (Ikebuchi et al., 1987; Koike et al., 1988) . In our system, however, r-IL-6 showed little effect on the reconstitution with Thy-l-lo/BM. One may argue that r-IL-6 should have some effect on the expansion and differentiation of Thy-l-lo/Thym or Thy-l-lo/BM, since these cells pass through the Thy-I+/IL2R / stage on the process of differentiation. In fact, the treatment with r-IL-6 sometimes enhanced the expansion of Thy-l-lo/Thym; we observed 2 to 3 times more progeny of Thy-l-lo/ Thym in r-IL-6-treated mouse in Exp. 1 of (1988) showed that anti-IL-2R cz-chain antibodies and 30-40% of double-negative thymocytes blocked the generation of mature T cells in thymic belonged to this fraction. This fraction was used as organ culture as well as in vivo, demonstrating an Thy-I+/IL2R /. To obtain Thy-l-lo/Thym, doubleimportance of IL-2-IL-2R interaction in thymocyte negative thymocytes enriched as described before differentiation. Effects of IL-2 on the development of were stained with FITC-anti-CD4, FITC-anti-CD8, precursor T cells have been suggested (Toribio et (Hirata et al., 1989; Takeshita et al., 1989) . population was approximately 0.5% of total bone Therefore, reagents against murine counterparts of marrow cells and used as Thy-l-lo/BM. All the them will enable us to do more detailed studies on sorting and analysis were done with FACS 440 dualthe role of these growth factors on T-cell matura-laser dye-laser cell sorter (Becton Dickinson, tion.
Mountain View, CA).
MATERIALS AND METHODS
Precursor-Cell Transfer and Analysis
Antibodies Sorted precursor populations from C3H/HeN mice (Thy-l.2) were resuspended in Hanks' balanced salt Monoclonal antibodies (mAbs) were purified from solution and injected intrathymically into 7-10 culture supernatants of hybridomas 53-6.7 (anti-week-old female AKR/J mice (Thy-l.1) that had CD8) (Ledbetter et al., 1982) , (anti-CD4) been y-irradiated (690 rad). Methods of injection (Dialynas et al., 1983) , 53-7.3 (anti-CDS), MAR18.5 were described previously (Goldschneider et al:, (mouse anti-rat Ig:), 30H12 (anti-Thyl.2) (Ledbetter 1986) . For the analysis of donor-derived cells, et al., 1979) , PC61 (anti-IL-2R) (Ceredig et al., 1985) , thymocytes or lymph node cells were routinely M1/70 (anti-Mac-I) (Springer et al., 1979) and 53-stained with FITC-anti-CD8, PC-anti-CD4, and PE-10.1 (Ledbetter et al., 1979) as previously described anti-Thy-l.2, or with another combination using (Hardy, 1986) . Fluorescein (FITC), biotin (bi) or FITC-anti-CD8, PE-anti-CD4, and PC-anti-Thy-l.2, phycobiliprotein labeling has been described (Hardy, and (Muller-Sieburg et al., 1986 ) by treating with a cock-Human r-IL-6 has been described (Hirano et al., tail of antithymocyte antibodies (53-6.7, GK1.5, 53-1986) . Human r-IL-2 was a kind gift of Ajinomoto 7.3), and with MAR18.5 as a facilitating reagent. Co. Ltd., Tokyo. Ten/zg of either r-IL-2 or r-IL-6 in After treatment with rabbit complement (low-tox-M, 200/l saline were injected intravenously immediCedarlane, Ontario, Canada), approximately 90% ately after cell transfer. Following days, the same pure double-negative thymocytes were obtained, amount of interleukins was injected into the perito-neal cavity once a day. Control mice were injected with the same volume of saline.
